Focus Diagnostic Centre Offers the Best PET Scan in Bangalore
Best PET Scan in Bangalore
Among all the diagnostic centers in Bangalore, one of the best is Focus Diagnostic Centre. This pet clinic offers excellent service at affordable prices. The maintenance facilities inside the healthcare premises are hygienic. A whole body CT scan is priced around 11,000 rupees. Other rates are slightly lower. However, one must be careful about the overall cost of the scan before making the booking. The following are some points to consider before making your booking.
First, choose a clinic that has a Best Pet Scan in Bangalore. This is an important diagnostic tool because it is capable of detecting bone problems. Bone pet scans have been an option for a few years, but they proved to be expensive and missed the bone problem in its early stage. A bone tumor is hard to detect at the early stage, so patients should ensure that their pets have access to a PET-CT scanner before booking their appointment.
A PET-CT Scan can also help detect hidden diseases. Many viral diseases become incurable if not detected and treated. A PET-CT scan can also detect cancer, one of the most deadly diseases for pets. Hence, it is essential to choose a centre with a PET-CT scanner that offers full body scanning. You may be able to save your pet’s life and yours! It’s time to take your pet for its annual checkup.
A PET-CT scan is one of the best diagnostic tools in Bangalore. It uses special radioactive tracers and dye that are absorbed by certain organs and tissues. The PET scanner detects the tracers, and thus gives an accurate picture of the functioning of the organs and tissues in the body. A PET scan can be done on any type of pet, whether small or large, and is a safe, outpatient procedure.
Focus Diagnostic Centre Offers the Best PET Scan in Bangalore
For certain men with prostate disease, results from an enormous clinical preliminary propose that there might be a more compelling imaging way to deal with recognize the spread of their malignant growth to different pieces of the body than the methodology that is generally ordinarily utilized.
Led in Australia, the preliminary included men determined to have confined prostate malignant growth that was believed to be at high gamble of spreading past the prostate. In the review, an imaging strategy known as PSMA PET-CT was significantly bound to identify metastatic cancers in these men than the standard imaging approach utilized in numerous nations, which includes a CT check and a bone output.
Utilization of PSMA PET-CT likewise was more probable than the standard way to deal with change the technique specialists used to treat the malignant growth, the preliminary’s lead examiner, Michael Hofman, a teacher of Nuclear Medicine at the Peter MacCallum Cancer Center in Melbourne, and his partners revealed March 22 in The Lancet.
The preliminary was not intended to show whether utilizing PSMA PET-CT further developed clinical results like how long patients lived. Yet, the outcomes, Dr. Hofman expressed, expand on proof from different examinations and current clinical practice in nations like Australia and Germany that propose PSMA PET-CT is bound to identify metastases than the customary methodology.